These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3497611

  • 1. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor.
    Pixley RA, Schmaier A, Colman RW.
    Arch Biochem Biophys; 1987 Aug 01; 256(2):490-8. PubMed ID: 3497611
    [Abstract] [Full Text] [Related]

  • 2. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA, Schapira M, Colman RW.
    Blood; 1985 Jul 01; 66(1):198-203. PubMed ID: 3873967
    [Abstract] [Full Text] [Related]

  • 3. Structural and functional characterization of factor XII.
    Tans G, Rosing J.
    Semin Thromb Hemost; 1987 Jan 01; 13(1):1-14. PubMed ID: 3551074
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M.
    J Clin Invest; 1984 Jun 01; 73(6):1542-9. PubMed ID: 6725552
    [Abstract] [Full Text] [Related]

  • 5. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Jun 01; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T, Kato H, Iwanaga S, Takada K, Sakakibara S.
    Eur J Biochem; 1985 Jan 02; 146(1):43-50. PubMed ID: 3871394
    [Abstract] [Full Text] [Related]

  • 8. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T, Sugo T, Kato H, Yoshida K, Iwanaga S.
    J Biochem; 1985 Feb 02; 97(2):429-39. PubMed ID: 2861197
    [Abstract] [Full Text] [Related]

  • 9. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
    Schapira M, Ramus MA, Jallat S, Carvallo D, Courtney M.
    J Clin Invest; 1986 Feb 02; 77(2):635-7. PubMed ID: 3484756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct 02; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 12. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE.
    Blood; 1988 Dec 02; 72(6):1841-8. PubMed ID: 3264190
    [Abstract] [Full Text] [Related]

  • 13. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP, Joseph K.
    Clin Rev Allergy Immunol; 2016 Oct 02; 51(2):207-15. PubMed ID: 27273087
    [Abstract] [Full Text] [Related]

  • 14. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW.
    Thromb Haemost; 1991 Nov 01; 66(5):540-7. PubMed ID: 1725067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of C1 inhibitor upon Hageman factor autoactivation.
    Weiss R, Silverberg M, Kaplan AP.
    Blood; 1986 Jul 01; 68(1):239-43. PubMed ID: 3487356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.